These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 9506347)

  • 41. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
    Schleusener JT; Tazelaar HD; Jung SH; Cha SS; Cera PJ; Myers JL; Creagan ET; Goldberg RM; Marschke RF
    Cancer; 1996 Apr; 77(7):1284-91. PubMed ID: 8608504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemoradiation in advanced nonsmall cell lung cancer.
    Pisch J; Berson AM; Malamud S; Beattie EJ; Harvey J; Vikram B
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):183-8. PubMed ID: 7642417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer.
    Shaw EG; Deming RL; Creagan ET; Nair S; Su JQ; Levitt R; Steen PD; Wiesenfeld M; Mailliard JA
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):827-31. PubMed ID: 7860395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concurrent cisplatin and etoposide with radiotherapy in locally advanced non-small cell lung cancer.
    Friess GG; Baikadi M; Harvey WH
    Cancer Treat Rep; 1987; 71(7-8):681-4. PubMed ID: 3038313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy and radiation in the nonoperative management of stage III non-small-cell lung cancer: the right chemotherapy works in the right setting.
    Green MR
    Important Adv Oncol; 1993; ():125-37. PubMed ID: 8389320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients.
    Jeremić B; Miličić B; Milisavljevic S
    Cancer; 2011 Jul; 117(13):2995-3003. PubMed ID: 21692056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
    Brizel DM; Albers ME; Fisher SR; Scher RL; Richtsmeier WJ; Hars V; George SL; Huang AT; Prosnitz LR
    N Engl J Med; 1998 Jun; 338(25):1798-804. PubMed ID: 9632446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
    Wagner W; von Eiff M; Klinke F; Micke O; Rübe C; Willich N
    Strahlenther Onkol; 1995 Jul; 171(7):390-7. PubMed ID: 7631260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radiochemotherapy of non-small-cell bronchial carcinoma. A report of experience].
    Müller G; Kiricuta IC; Stiess J; Flentje M
    Strahlenther Onkol; 1996 Aug; 172(8):446-54. PubMed ID: 8765348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recent changes in the management of advanced non-small cell lung cancer].
    Kodama N; Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
    Depierre A; Milleron B; Lebeau B; Moro D; Chastang C; Jacoulet P; Paillot N; Quoix E; Janicot H; Lombard JN
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):16-9. PubMed ID: 8209272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.
    Rosell R; Gómez-Codina J; Camps C; Maestre J; Padille J; Cantó A; Mate JL; Li S; Roig J; Olazábal A
    N Engl J Med; 1994 Jan; 330(3):153-8. PubMed ID: 8043059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined chemoradiation for locally advanced nonsmall cell lung cancer.
    Dubray B; Livartowski A; Beuzeboc P; Pouillart P; Cosset JM
    J Infus Chemother; 1995; 5(4):195-6. PubMed ID: 8934726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging.
    Kirn DH; Lynch TJ; Mentzer SJ; Lee TH; Strauss GM; Elias AD; Skarin AT; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):696-702. PubMed ID: 8412265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The results of the endoluminal high-dose-rate irradiation of central non-small cell bronchial carcinomas].
    Schraube P; Fritz P; Becker HD; Wannenmacher M
    Strahlenther Onkol; 1993 Apr; 169(4):228-34. PubMed ID: 8387698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC).
    Baumann M; Herrmann T; Koch R; Matthiessen W; Appold S; Wahlers B; Kepka L; Marschke G; Feltl D; Fietkau R; Budach V; Dunst J; Dziadziuszko R; Krause M; Zips D;
    Radiother Oncol; 2011 Jul; 100(1):76-85. PubMed ID: 21757247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
    Kubota K; Hida T; Ishikura S; Mizusawa J; Nishio M; Kawahara M; Yokoyama A; Imamura F; Takeda K; Negoro S; Harada M; Okamoto H; Yamamoto N; Shinkai T; Sakai H; Matsui K; Nakagawa K; Shibata T; Saijo N; Tamura T;
    Lancet Oncol; 2014 Jan; 15(1):106-13. PubMed ID: 24309370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.